Subscribe to Newsletter

Farhad Hafezi

Farhad Hafezi

Farhad Hafezi is a Professor of Ophthalmology at the University of Geneva, Switzerland; Research Group Leader at the CABMM of the University of Zurich, Switzerland; Chief Medical Officer of the ELZA Institute, Zurich, Switzerland; Adjunct Clinical Professor of Ophthalmology at the USC Roski Eye Institute, Los Angeles, USA; Research Professor at the NYU Grossman School of Medicine, New York, and Visiting Professor at the Wenzhou Medical University, Wenzhou, China.

Content by Farhad Hafezi:

Subspecialties Cornea / Ocular Surface

Rehabilitating Vision After Keratoconus

| Farhad Hafezi, Emilio de Almeida Torres-Netto | 7 min read

TransPRK, PACE, and All Femto-CAIRS as surgical options for keratoconus

Subspecialties Cornea / Ocular Surface

Corneal Cross-Linking: What’s New in 2023?

| Farhad Hafezi | 7 min read

Farhad Hafezi - newest breakthroughs in keratoconus

Subspecialties COVID-19

Education Without Borders

| Farhad Hafezi

From the podium to the webinar platform: providing access to learning for everyone

Subspecialties Pediatric

Think PINCO

| Farhad Hafezi

How should we persuade children – particularly those with communication challenges – to co-operate during ophthalmic examinations?

Subspecialties Cornea / Ocular Surface

CXL Unbound

| Farhad Hafezi

What drives progress in medicine? Identifying and meeting unmet needs

Subspecialties Cornea / Ocular Surface

Unlocking CXL’s Molecular Mysteries – With Mice

| Farhad Hafezi

Swiss researchers have developed methods for performing corneal crosslinking with riboflavin and corneal biomechanical testing in mice – opening up the world of transgenics and molecular testing.

Subspecialties Cornea / Ocular Surface

PACK-CXL For All

| Farhad Hafezi

The concept of using photoactivated chromophores for corneal cross-linking (PACK-CXL) as a weapon against infectious keratitis is compelling. The evidence suggests that PACK-CXL could have a dramatic impact on a major cause of global blindness… but only if the expensive, bulky technology (and the requirement for a corneal surgeon in a sterile operating theater) can be overcome. One company may have the answer.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: